In prostate cancer, BRD4 is most extensively studied, and one of the BRD4-mediated oncogenic mechanisms involves the elevation of key oncogenic drivers like c-Myc, which can substantially contribute to the uncontrolled growth of cancer cells. The gene discussed is BRD4; the disease is cancer.